Table 1.
Distribution of demographic and tumor characteristics of ovarian cancer cases by race/ethnicity, 1990–2014.
| Characteristic | Non-Hispanic White* | Asian Indian/Pakistani* | Chinese* | Filipino* | Japanese* | Korean* | Vietnamese* | Chi-square P-value† | Chi-square P-value‡ |
|---|---|---|---|---|---|---|---|---|---|
| Total: | 84,416 | 680 | 1,559 | 1,978 | 1,091 | 552 | 578 | ||
| Age at diagnosis | < 0.0001 | < 0.0001 | |||||||
| < 40 years | 3,340 (3.96) | 91 (13.38) | 134 (8.60) | 168 (8.49) | 61 (5.59) | 47 (8.51) | 68 (11.76) | ||
| 40–49 years | 9,665 (11.45) | 151 (22.21) | 348 (22.32) | 418 (21.13) | 149 (13.66) | 120 (21.74) | 146 (25.26) | ||
| 50–59 years | 17,077 (20.23) | 177 (26.03) | 405 (25.98) | 562 (28.41) | 237 (21.72) | 169 (30.62) | 164 (28.37) | ||
| 60–69 years | 19,803 (23.46) | 132 (19.41) | 265 (17.00) | 408 (20.63) | 251 (23.01) | 111 (20.11) | 112 (19.38) | ||
| 70–79 years | 19,572 (23.19) | 91 (13.38) | 231 (14.82) | 294 (14.86) | 240 (22.00) | 60 (10.87) | 54 (9.34) | ||
| 80+ years | 14,959 (17.72) | 38 (5.59) | 176 (11.29) | 128 (6.47) | 153 (14.02) | 45 (8.15) | 34 (5.88) | ||
| Tumor Histotype | < 0.0001 | < 0.0001 | |||||||
| Serous | 50,732 (60.10) | 394 (57.94) | 698 (44.77) | 948 (47.93) | 514 (47.11) | 306 (55.43) | 285 (49.31) | ||
| Mutinous | 5,546 (6.57) | 43 (6.32) | 144 (9.24) | 196 (9.91) | 107 (9.81) | 51 (9.24) | 64 (11.07) | ||
| Endometrioid | 8,886 (10.53) | 83 (12.21) | 210 (13.47) | 296 (14.96) | 156 (14.30) | 59 (10.69) | 74 (12.80) | ||
| Clear cell | 3,846 (4.56) | 50 (7.35) | 213 (13.66) | 194 (9.81) | 128 (11.73) | 47 (8.51) | 68 (11.76) | ||
| Other/NOS** | 15,406 (18.25) | 110 (16.18) | 294 (18.86) | 344 (17.39) | 186 (17.05) | 89 (16.12) | 87 (15.05) | ||
| Tumor Grade*** | < 0.0001 | 0.14 | |||||||
| Low | 5,819 (6.89) | 49 (7.21) | 139 (8.92) | 156 (7.89) | 80 (7.33) | 51 (9.24) | 53 (9.17) | ||
| High | 48,643 (57.62) | 408 (60.00) | 898 (57.60) | 1162 (58.75) | 693 (63.52) | 312 (56.52) | 335 (57.96) | ||
| Unknown | 29,954 (35.48) | 223 (32.79) | 522 (33.48) | 660 (33.37) | 318 (29.15) | 189 (34.24) | 190 (32.87) | ||
| Tumor stage | < 0.0001 | 0.0002 | |||||||
| Localized | 12,297 (14.57) | 126 (18.53) | 407 (26.11) | 434 (21.94) | 274 (25.11) | 123 (22.28) | 149 (25.78) | ||
| Regional | 5,686 (6.74) | 52 (7.65) | 129 (8.27) | 219 (11.07) | 87 (7.97) | 50 (9.06) | 60 (10.38) | ||
| Distant | 49,882 (59.09) | 407 (59.85) | 863 (55.36) | 1,118 (56.52) | 616 (55.46) | 318 (57.61) | 321 (55.54) | ||
| Unknown | 16,551 (19.61) | 95 (13.97) | 160 (10.26) | 207 (10.47) | 114 (10.45) | 61 (11.05) | 48 (8.30) |
Abbreviation: NOS = not otherwise specified.
*
Number of ovarian cancer cases (percent of ovarian cancer cases).
†
Across non-Hispanic whites and all six Asian ethnicities.
‡
Across the six Asian ethnicities only.
**
Includes carcinosarcomas as well as mixed, other, undifferentiated, and unspecified tumors.
***
Low grade includes well-differentiated tumors only. High grade includes moderately differentiated, poorly differentiated, and undifferentiated tumors.